SC3 Research - Pasadena - 960 E. Green St

Clinical research site in Pasadena, California

As of July 2026, 1 paid clinical trial is recruiting at SC3 Research - Pasadena - 960 E. Green St in Pasadena, California. Active studies at this site focus on Psychosis Associated With Alzheimer's Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at SC3 Research - Pasadena - 960 E. Green St (1)

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

for Psychosis Associated With Alzheimer's Disease

86 locations incl. Gilbert

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All·Age: 55 - 90

Code: NCT05980949·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

More research sites in Pasadena

Huntington Memorial Hospital (11 trials)
Keck Medical Center of USC Pasadena (7 trials)
California Liver Research Institute (4 trials)
Profound Research LLC at Southern California Heart Specialists (4 trials)
GSK Investigational Site (3 trials)
Kaiser Permanente Southern California (3 trials)
Pasadena Clinical Trials (3 trials)
Profound Research LLC (3 trials)
89bio Clinical Study Site (2 trials)
Akero Clinical Study Site (2 trials)

Explore more

Paid clinical trials in Pasadena, CA · California clinical trials